Prothena Corp PLC (PRTA)
47.07
-1.00 (-2.08%)
USD |
NASDAQ |
Mar 24, 16:00
48.01
+0.94 (+2.00%)
After-Hours: 20:00
Prothena Enterprise Value: 1.764B for March 24, 2023
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| March 24, 2023 | 1.764B |
| March 23, 2023 | 1.816B |
| March 22, 2023 | 1.759B |
| March 21, 2023 | 1.872B |
| March 20, 2023 | 1.820B |
| March 17, 2023 | 1.827B |
| March 16, 2023 | 1.864B |
| March 15, 2023 | 1.867B |
| March 14, 2023 | 1.837B |
| March 13, 2023 | 1.835B |
| March 10, 2023 | 1.812B |
| March 09, 2023 | 1.926B |
| March 08, 2023 | 2.061B |
| March 07, 2023 | 2.023B |
| March 06, 2023 | 2.095B |
| March 03, 2023 | 2.130B |
| March 02, 2023 | 2.074B |
| March 01, 2023 | 2.231B |
| February 28, 2023 | 2.221B |
| February 27, 2023 | 2.158B |
| February 24, 2023 | 2.155B |
| February 23, 2023 | 1.965B |
| February 22, 2023 | 2.028B |
| February 21, 2023 | 1.990B |
| February 17, 2023 | 2.098B |
| Date | Value |
|---|---|
| February 16, 2023 | 2.026B |
| February 15, 2023 | 2.099B |
| February 14, 2023 | 2.115B |
| February 13, 2023 | 2.101B |
| February 10, 2023 | 2.071B |
| February 09, 2023 | 2.149B |
| February 08, 2023 | 2.172B |
| February 07, 2023 | 2.270B |
| February 06, 2023 | 2.326B |
| February 03, 2023 | 2.299B |
| February 02, 2023 | 2.184B |
| February 01, 2023 | 2.086B |
| January 31, 2023 | 2.236B |
| January 30, 2023 | 2.153B |
| January 27, 2023 | 2.266B |
| January 26, 2023 | 2.200B |
| January 25, 2023 | 2.168B |
| January 24, 2023 | 2.202B |
| January 23, 2023 | 2.161B |
| January 20, 2023 | 2.132B |
| January 19, 2023 | 2.101B |
| January 18, 2023 | 2.142B |
| January 17, 2023 | 2.198B |
| January 13, 2023 | 2.254B |
| January 12, 2023 | 2.286B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-123.26M
Minimum
Aug 23 2019
3.154B
Maximum
Sep 23 2021
708.30M
Average
180.12M
Median
Aug 24 2020
Enterprise Value Benchmarks
| Mallinckrodt PLC | 2.793B |
| Jazz Pharmaceuticals PLC | 13.79B |
| Nabriva Therapeutics PLC | -3.153M |
| Iterum Therapeutics PLC | -20.16M |
| GH Research PLC | 246.57M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 6.349M |
| Revenue (Quarterly) | 49.92M |
| Total Expenses (Quarterly) | 50.00M |
| EPS Diluted (Quarterly) | 0.12 |
| Profit Margin (Quarterly) | 12.72% |
| Earnings Yield | -5.33% |
| Normalized Earnings Yield | -5.332 |